FDA approves Viread for hep B treatment
Posted on August 14, 2008
Filed Under Gay Wired, News
The United States joins Europe, Turkey, Australia and New Zealand in allowing Gilead to market the AIDS drug as suppressing the chronic liver disease.
FDA approves Viread for hep B treatmentUN: New HIV Infections Outpace Drug Treatment
Senate Approves Repeal of HIV Travel and Immigration Ban
Senate Approves Repeal of HIV Travel and Immigration Ban
Health Warning Over HIV Drug Linked To Serious Liver Side Effects
Comments
